This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday

ADC Therapeutics
Cerebras Systems
Cognizant Technology
Dave
GE Aerospace

ADC Therapeutics

ADCT

0.00

Cerebras Systems

CBRS

0.00

Cognizant Technology

CTSH

0.00

Dave

DAVE

0.00

GE Aerospace

GE

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • HC Wainwright & Co. analyst Robert Burns downgraded ADC Therapeutics SA (NYSE:ADCT) from Buy to Neutral. ADC Therapeutics shares closed at $1.0250 on Friday. See how other analysts view this stock.
  • Wells Fargo analyst Elyse Greenspan downgraded W. R. Berkley Corporation (NYSE:WRB) from Equal-Weight to Underweight and lowered the price target from $64 to $58. WR Berkley shares closed at $68.57 on Friday. See how other analysts view this stock.

Considering buying ADCT stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.